Medical Science News

RSS

Discovery of how NK cells are regulated in peripheral tissues could help combat cancer, other diseases

New research reveals factors that control the interplay of natural killer (NK) cells - which are part of the body's innate, or first line, immune response - with tumor cells, viral infections, and solid organ transplants.

16 Mar 2022

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases.

16 Mar 2022

Elevated triglyceride levels may increase risk of second stroke, even while on statin therapy

Stroke can have many causes. An atherothrombotic stroke is caused by a clot that forms from plaques that build up within blood vessels in the brain.

16 Mar 2022

Neurons that drive competition and social behavior within groups discovered

New research in mice has identified neurons in the brain that influence competitive interactions between individuals and that play a critical role in shaping the social behavior of groups.

16 Mar 2022

Penn State professor receives $2.8 million NIH grant to investigate lower jaw development

How the lower jaw - mandible - develops and consequently how and why some developmental birth defects occur is the focus of a five-year, $2.8 million grant to Joan Richtsmeier, distinguished professor of anthropology, Penn State, from the National Institutes of Health's National Institute of Dental & Craniofacial Research.

16 Mar 2022

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

A small preliminary study from Northwestern Medicine has shown that a blood test may identify risk of stillbirth and placentitis in pregnant individuals who have had COVID-19.

16 Mar 2022

Study delineates how drug-induced changes of conscious awareness are rooted in neurotransmitter receptors

Psychedelics are now a rapidly growing area of neuroscience and clinical research, one that may produce much-needed new therapies for disorders such as depression and schizophrenia.

16 Mar 2022

Potential Covid-19 vaccine may offer an inexpensive, easy-to-store alternative to RNA vaccines

While many people in wealthier countries have been vaccinated against Covid-19, there is still a need for vaccination in much of the world.

16 Mar 2022

Study finds a promising new target for immunity-boosting cancer treatments

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.

16 Mar 2022

UQ researchers discover a molecule essential for regulating nerve repair

Researchers at The University of Queensland have identified a molecule essential for regulating the repair of injured nerves, which could help people recover from nerve damage.

16 Mar 2022

Multisystem inflammatory syndrome as a late complication in COVID-19 infected children

Researchers determined the immune signature of the multisystem inflammatory syndrome in children among hospitalized children diagnosed with SARS‐CoV‐2 infection.

16 Mar 2022

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Researchers estimate the impact of COVID-19 booster doses on infection in a vaccinated population of young adults during Omicron-dominant period.

16 Mar 2022

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

We speak to Dr. Alemnew Dagnew from the Bill & Melinda Gates Medical Research Institute, about their tuberculosis vaccine study and the future of tuberculosis.

16 Mar 2022

Novel targets to inhibit SARS-CoV-2 variants

A new study identified additional targets on SARS-CoV-2 proteins to prevent the emergence of new SARS-CoV-2 variants of concern.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

Medical Science News

Discovery of how NK cells are regulated in peripheral tissues could help combat cancer, other diseases

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

Elevated triglyceride levels may increase risk of second stroke, even while on statin therapy

Neurons that drive competition and social behavior within groups discovered

Penn State professor receives $2.8 million NIH grant to investigate lower jaw development

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

Study delineates how drug-induced changes of conscious awareness are rooted in neurotransmitter receptors

Potential Covid-19 vaccine may offer an inexpensive, easy-to-store alternative to RNA vaccines

Study finds a promising new target for immunity-boosting cancer treatments

UQ researchers discover a molecule essential for regulating nerve repair

Multisystem inflammatory syndrome as a late complication in COVID-19 infected children

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

Novel targets to inhibit SARS-CoV-2 variants

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

Discovery of key brain pathway offers potential new drug target for treating anxiety

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

Acacetin shows potency against SARS-CoV-2 spike protein

Study reveals the oncometabolite role of progesterone in advanced prostate cancer

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News